Notably, Zhang et al. demonstrated the neuroprotective potential of diphenyl diselenide by inhibiting the NF-κB pathway and NLRP3 inflammasome activation, suggesting it as a promising treatment for ALS [112]. The gene discussed is NLRP3; the disease is amyotrophic lateral sclerosis.